Oncolytics Biotech Inc
(ONCY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 8,966 | 10,575 | 10,657 | 11,635 | 14,365 |
| Receivables | 39 | 52 | 62 | 50 | 76 |
| Other current assets | 0 | 740 | 850 | 715 | 801 |
| TOTAL | $10,200 | $13,662 | $12,874 | $13,775 | $16,795 |
| Non-Current Assets | |||||
| PPE Net | 244 | 254 | 269 | 300 | 309 |
| Other Non-Current Assets | 486 | 526 | 577 | 658 | 680 |
| TOTAL | $730 | $779 | $846 | $958 | $989 |
| Total Assets | $10,930 | $14,441 | $13,721 | $14,733 | $17,784 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,211 | 3,821 | 3,446 | 3,497 | 5,074 |
| Other current liabilities | 145 | 710 | 369 | 1,181 | 358 |
| TOTAL | $5,557 | $4,741 | $4,017 | $4,880 | $5,616 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 5,290 | 5,297 | 5,181 | 5,486 | 5,529 |
| TOTAL | $5,290 | $5,297 | $5,181 | $5,486 | $5,529 |
| Total Liabilities | $10,846 | $10,039 | $9,198 | $10,366 | $11,145 |
| Shareholders' Equity | |||||
| Common Shares | 332,920 | 326,176 | 310,269 | 319,793 | 318,459 |
| Retained earnings | -366,554 | -354,679 | -337,336 | -348,635 | -344,287 |
| Other shareholders' equity | 573 | 521 | 667 | 701 | 479 |
| TOTAL | $84 | $4,402 | $4,522 | $4,366 | $6,639 |
| Total Liabilities And Equity | $10,930 | $14,441 | $13,721 | $14,733 | $17,784 |